Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
EMT signaling: potential contribution of CRISPR/Cas gene editing.
Mohammadinejad R, Biagioni A, Arunkumar G, Shapiro R, Chang KC, Sedeeq M, Taiyab A, Hashemabadi M, Pardakhty A, Mandegary A, Thiery JP, Aref AR, Azimi I. Mohammadinejad R, et al. Among authors: biagioni a. Cell Mol Life Sci. 2020 Jul;77(14):2701-2722. doi: 10.1007/s00018-020-03449-3. Epub 2020 Feb 1. Cell Mol Life Sci. 2020. PMID: 32008085 Free PMC article. Review.
CRISPR/Cas9 uPAR Gene Knockout Results in Tumor Growth Inhibition, EGFR Downregulation and Induction of Stemness Markers in Melanoma and Colon Carcinoma Cell Lines.
Biagioni A, Chillà A, Del Rosso M, Fibbi G, Scavone F, Andreucci E, Peppicelli S, Bianchini F, Calorini L, Li Santi A, Ragno P, Margheri F, Laurenzana A. Biagioni A, et al. Front Oncol. 2021 May 14;11:663225. doi: 10.3389/fonc.2021.663225. eCollection 2021. Front Oncol. 2021. PMID: 34055629 Free PMC article.
Editing SOX Genes by CRISPR-Cas: Current Insights and Future Perspectives.
Dehshahri A, Biagioni A, Bayat H, Lee EHC, Hashemabadi M, Fekri HS, Zarrabi A, Mohammadinejad R, Kumar AP. Dehshahri A, et al. Among authors: biagioni a. Int J Mol Sci. 2021 Oct 20;22(21):11321. doi: 10.3390/ijms222111321. Int J Mol Sci. 2021. PMID: 34768751 Free PMC article. Review.
Delivery systems of CRISPR/Cas9-based cancer gene therapy.
Biagioni A, Laurenzana A, Margheri F, Chillà A, Fibbi G, Del Rosso M. Biagioni A, et al. J Biol Eng. 2018 Dec 18;12:33. doi: 10.1186/s13036-018-0127-2. eCollection 2018. J Biol Eng. 2018. PMID: 30574185 Free PMC article. Review.
uPAR Controls Vasculogenic Mimicry Ability Expressed by Drug-Resistant Melanoma Cells.
Andreucci E, Laurenzana A, Peppicelli S, Biagioni A, Margheri F, Ruzzolini J, Bianchini F, Fibbi G, Del Rosso M, Nediani C, Serrat S, Fucci L, Guida M, Calorini L. Andreucci E, et al. Among authors: biagioni a. Oncol Res. 2022 Jan 31;28(9):873-884. doi: 10.3727/096504021X16273798026651. Epub 2021 Jul 27. Oncol Res. 2022. PMID: 34315564 Free PMC article.
76 results